2 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp05013 | Omiganan MBI-226 | ILRWPWWPWRRK | Helical peptide with a predominance of one or more amino acids tryptophane-rich | Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis | MTT/MTS assay | U-937 | Lymphoma cancer | 27% Cytotoxicity at 0.5 µg/ml |
| dbacp05489 | Pexiganan MSI-78 | GIGKFLKKAKKFGKAFVKILKK | Helical peptide with a predominance of one or more amino acids tryptophane-rich | Disruption of membrane permeability | MTT/MTS assay | U-937 | Lymphoma cancer | 75% Cytotoxicity at 0.5 µg/ml |